Nuvation Bio Inc. (NUVB) Return on equity 2023–2025
Nuvation Bio Inc. (NUVB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-66.9%FY2025 · since FY2023: -12.5% → -66.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -66.9% | +55.5 pp |
| FY2024 | -122.5% | -109.9 pp |
| FY2023 | -12.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NUVB financial trends
NUVB RevenueNUVB Net incomeNUVB Net marginNUVB Gross profitNUVB Gross marginNUVB Operating incomeNUVB Operating marginNUVB Operating cash flowNUVB Free cash flowNUVB Capital expendituresNUVB Stock buybacksNUVB Dividends paidNUVB Total assetsNUVB Total liabilitiesNUVB Shareholders’ equityNUVB overview →